1Lacourciere Y, Lehis J,R Omhard,et al.A comparison of thee cacies and duration of action of the angiotensin II receptor blockers tel- misartan and amledipine[J].Blood Press Monit,1998,3(5):295-302.
2Chobanian AV, Bakris GL,Black HR,et al.The seventh report of the Joint National Committee on Prevention,Detection,Evaluation, and Treatment of High Blood Pressure:the JNC7 report[J].JAMA, 2003,289(19):2560 -2571.
5Urger T.Pharmacology of AT l-recepter blocker blood press,2001, 101(suppl 3):1-6.
6Marino Mr,Langenvacher K,Ford NF, et al. Pharmacokinetics andpharmacodynamics of Irbesartan in health subjects[J]. J Clin Pha- __ r macoI,1998,38(3.):276-275:.
7Weber MA, Fodera SM. Circadian variations in cardiovascular disease chronotherapeutic approaches to the management of hypertension [J]. Rev Cardiovasc Med, 2004,5 (3) : 148-155.
8Stergiou GS, Vemmos KN, Pliarchopoulou KM, etal. Paral-lel morning and evening surge in stroke onset, blood pressure, and physical activity[J]. Stroke, 2002, 33(6) : 1480-1486.
9Reiter MJ. Cardiovascular drug class specificity:beta- blockers [J]. Prog Cardiovasc Dis, 2004,47 ( 1 ) : 11-33.
